Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 1—January 2008
International Polar Year

Invasive Bacterial Diseases in Northern Canada

Naushaba Degani*, Christine Navarro†, Shelley L. Deeks†1Comments to Author , Marguerite Lovgren‡, and the Canadian International Circumpolar Surveillance Working Group
Author affiliations: *Hospital for Sick Children, Toronto, Ontario, Canada; †Public Health Agency of Canada, Ottawa, Ontario, Canada; ‡National Centre for Streptococcus, Edmonton, Alberta, Canada;

Main Article

Table 1

Total and age-specific population estimates for the Canadian circumpolar region and entire population, 2001 census (1)

RegionTotalAge, no. (%)
<2 y2–4 y5–19 y20–64 y>65 y
Circumpolar*132,9564,849 (3.7)7,414 (5.6)37,431 (28.2)77,823 (58.5)5,439 (4.1)
Canada†30,007,095652,120 (2.2)1,044,160 (3.5)6,082,585 (20.3)18,339,680 (61.1)3,888,550 (13.0)

*Yukon, Northwest Territories, Nunavut, northern Québec, and northern Labrador.
†Includes the circumpolar region.

Main Article

  1. Statistics Canada. 2001 Census of population. Statistics Canada. 2001 [cited 2006 Dec 1]. Available from
  2. Statistics Canada. Aboriginal peoples of Canada: a demographic profile. 2001 census analysis series. 2006 [cited 2006 Dec 1]. Available from
  3. Vaudry W, Talling D. Invasive pneumococcal infection in First Nations children in Northern Alberta.Can Commun Dis Rep. 2002;28:16572.PubMed
  4. Singleton R, Hammitt L, Hennessy T, Bulkow L, DeByle C, Parkinson A, The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.Pediatrics. 2006;118:e4219. DOIPubMed
  5. Christiansen J, Poulsen P, Ladefoged K. Invasive pneumococcal disease in Greenland.Scand J Infect Dis. 2004;36:3259. DOIPubMed
  6. National Advisory Committee on Immunization. Canadian immunization guide, 7th ed. Ottawa: Public Health Agency of Canada; 2006.
  7. Ruoff KL, Wiley RA, Beighton D. Streptococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology, 7th ed. Washington: American Society for Microbiology; 1999. p. 283–96.
  8. Lund R, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T, Norris JR, editors. Methods in microbiology. New York: Academic Press; 1978. p. 241–62.
  9. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae.J Clin Microbiol. 1995;33:275962.PubMed
  10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard 5th edition. Wayne (PA): The Committee; 2000. Report no. M7–A5.
  11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard 6th edition. Wayne (PA): The Committee; 2003. Report no. M7–A6.
  12. Johnson DR, Sramek J, Kaplan EI, Bicova R, Havlicek J, Havlickova H, Laboratory diagnosis of group A streptococcal infections. Geneva: World Health Organization; 1996.
  13. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, emm typing and validation of provisional M types for group A streptococci.Emerg Infect Dis. 1999;5:24753.PubMed
  14. Wilkinson HW, Moody MD. Serological relationships of type I antigens of group B streptococci.J Bacteriol. 1969;97:62934.PubMed
  15. Kilian M. Haemophilus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology, 8th ed. Washington: American Society for Microbiology; 2006. p. 623–35.
  16. Kilian M. A taxonomic study of the genus Haemophilus, with the proposal of a new species.J Gen Microbiol. 1976;93:962.PubMed
  17. Riou JY, Guibourdenche M. Laboratory methods: Neisseria and Branhamella. Paris: Institut Pasteur; 1992.
  18. Abdillahi H, Poolman JT. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA.J Med Microbiol. 1988;26:17780.PubMed
  19. Public Health Agency of Canada. Canadian National Report on Immunization, 2006. Can Commun Dis Rep 2006;32S3:1–44.
  20. Ndiaye AA, De Wals P, Proulx JF, Ouakki M, Jette L, Dery S. Impact of a mass immunization campaign to control an outbreak of severe respiratory infections in Nunavik, northern Canada.Int J Circumpolar Health. 2006;65:297304.PubMed
  21. Macey JF, Roberts A, Lior L, Tam TW, van Caeseele P. Outbreak of community-acquired pneumonia in Nunavut, October and November, 2000.Can Commun Dis Rep. 2002;28:1318.PubMed
  22. Hennessy TW, Singleton RJ, Bulkow LR, Bruden DL, Hurlburt DA, Parks D, Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance, and colonization in Alaska Natives: progress towards elimination of a health disparity.Vaccine. 2005;23:546473. DOIPubMed
  23. Roche PW, Krause VL, Bartlett M, Coleman D, Cook H, Davis C, Invasive pneumococcal disease in Australia, 2004.Commun Dis Intell. 2006;30:8092.PubMed
  24. Scheifele D, Halperin S, Law B, King A, Halperin S, Morris R, Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001–2003.CMAJ. 2005;172:536. DOIPubMed
  25. Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994–1995: near disappearance of a vaccine-preventable childhood disease.Emerg Infect Dis. 1998;4:22937.PubMed
  26. Millar EV, O’Brien KL, Watt JP, Lingappa J, Pallipamu R, Rosenstein N, Epidemiology of invasive Haemophilus influenzae type a disease among Navajo and White Mountain Apache children, 1988–2003.Clin Infect Dis. 2005;40:82330. DOIPubMed
  27. First Nations and Inuit Health Branch. A statistical profile on the health of First Nations in Canada. Ottawa: Health Canada; 2005.
  28. Banerji A, Bell A, Mills EL, McDonald J, Subbarao K, Stark G, Lower respiratory tract infections in Inuit infants on Baffin Island.CMAJ. 2001;164:184750.PubMed
  29. Kovesi T, Creery D, Gilbert NL, Dales R, Fugler D, Thompson B, Indoor air quality risk factors for severe lower respiratory tract infections in Inuit infants in Baffin Region, Nunavut: a pilot study.Indoor Air. 2006;16:26675. DOIPubMed
  30. Hammitt LL, Block S, Hennessy TW, Debyle C, Peters H, Parkinson A, Outbreak of invasive Haemophilus influenzae serotype a disease.Pediatr Infect Dis J. 2005;24:4536. DOIPubMed
  31. Gratten M, Morey F, Hanna J, Hagget J, Pearson M, Torzillo P, Type, frequency and distribution of Haemophilus influenzae in central Australian Aboriginal children with invasive disease.Med J Aust. 1994;160:7289.PubMed
  32. Losonsky GA, Santosham M, Sehgal V, Zwahlen A, Moxon ER. Haemophilus influenzae disease in the White Mountain Apaches: molecular epidemiology of a high risk population.Pediatr Infect Dis. 1984;3:53947.PubMed
  33. Tsang RS, Mubareka S, Sill ML, Wylie J, Skinner J, Skinner S, Invasive Haemophilus influenzae disease in Manitoba, Canada, in the postvaccination era.J Clin Microbiol. 2006;44:15305. DOIPubMed
  34. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome.JAMA. 1993;269:3849. DOIPubMed
  35. Carapetis JR, Walker AM, Hibble M, Sriprakash KS, Currie BJ. Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection.Epidemiol Infect. 1999;122:5965. DOIPubMed
  36. Galanis E, Skotniski E, Panaro L, Tam T, Dignan T. Investigation of a varicella outbreak complicated by group A streptococcus in First Nations communities, Sioux Lookout Zone, Ontario.Can Commun Dis Rep. 2002;28:15763.PubMed

Main Article

1Current affiliation: National Centre for Immunisation, Research and Surveillance, Westmead, New South Wales, Australia

2The Canadian International Circumpolar Surveillance Working Group includes the following members: Colleen Hemsley, Bryce Larke (Yukon Health and Social Services, Whitehorse, Yukon, Canada); Cheryl Case, Norine Fraley (Northwest Territories Health and Social Services, Yellowknife, Northwest Territories); Carolina Palacios (Canada Nunavut Health and Social Services, Iqaluit, Nunavut, Canada); Robert Carlin (Cree Board of Health and Social Services of James Bay, Montreal, Québec, Canada, and Ministère de Santé et Services Sociaux, Québec City, Quebec, Canada); Jean-François Proulx (Canada Direction de Santé Publique du Nunavik, Kuujjuak, Québec, Canada, and Ministère de Santé et Services Sociaux, Québec City, Quebec, Canada); Jane McGillivray, Paulette Roberts (Health Labrador Corporation, Happy Valley-Goose Bay, Labrador, Canada); Louise Jetté, Robert A. Laurence, Louise Ringuette (Laboratoire de Santé Publique du Québec Ste.-Anne-de-Bellevue, Québec, Canada); Marguerite Lovgren, Gregory Tyrrell (National Centre for Streptococcus, Edmonton, Alberta, Canada); Raymond Tsang (National Microbiology Laboratory, Winnipeg, Manitoba, Canada); Shelley L. Deeks, Christine Navarro, Nadine Abboud (Canada Public Health Agency of Canada, Ottawa, Ontario, Canada); Michael G. Bruce, Tammy Zulz (Centers for Disease Control and Prevention, Anchorage, Alaska, USA).

Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.